Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of isotope-labeled dianthrone compounds in the preparation of antitumor drugs

An isotope-labeled, anti-tumor drug technology, applied in the field of anti-tumor drugs and drugs, can solve the problems of difficult control of patients, infection, reduction of targeting and therapeutic effect, etc.

Inactive Publication Date: 2018-04-13
JIANGSU PROVINCE INST OF TRADITIONAL CHINESE MEDICINE
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Isotope-labeled hypericin and proto-hypericin have also been studied as tumor-targeting drugs. The compound, whose spatial structure is similar to a plane, is easy to form self-aggregation, which reduces its targeting and therapeutic effect, resulting in isotope-labeled hypericin and prohypericin staying in normal organs and reticuloendothelial system for a long time, causing Long-term damage to normal organs and myelosuppressive response in patients, resulting in uncontrollable infections in patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of isotope-labeled dianthrone compounds in the preparation of antitumor drugs
  • Application of isotope-labeled dianthrone compounds in the preparation of antitumor drugs
  • Application of isotope-labeled dianthrone compounds in the preparation of antitumor drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-2131I

[0022] Example 1-2 131 Preparation of I-labeled prohypericin

[0023] Weigh 1.0 mg of powdered protohypericin, dissolve it in 2.0 ml of DMSO, oscillate to obtain a 0.5 mg / ml protohypericin DMSO solution. Add 400 μl of protohypericin DMSO solution with a concentration of 0.5 mg / ml into the coated tube with a prepared lodogen content of 40 μg, and add 100 μl of 200 μCi Na 131 I solution, shake well, react at 20-25°C for about 60 minutes, take out the reaction solution to terminate the reaction, measure the labeling rate, and the labeling rate is greater than 90%, indicating that the labeling is successful. Measurement method of labeling rate: The labeling rate of the reaction solution was determined by paper chromatography, Whatman filter paper was used as the carrier, and 0.1mol / L HCl was used as the mobile phase for development. The labeling rate was measured by paper chromatography, and the free 131 I is distributed at the solvent front, while 131 I marks pro-hypericin to...

Embodiment 1-3131I

[0024] Example 1-3 131 Preparation of I-labeled sennoside A

[0025] Weigh 2.0mg of powdered sennoside A, dissolve in 1.0ml DMSO, shake well, and obtain 2.0mg / ml sennoside ADMSO solution. Add 400 μl of sennoside A DMSO solution with a concentration of 2.0 mg / ml into the coated tube with a prepared lodogen content of 40 μg, and add 100 μl of 200 μC Na 131 I solution, oscillate and shake well, heat in a water bath at 45°C, react for about 90 minutes, take out the reaction solution to terminate the reaction, measure the labeling rate, and the labeling rate is greater than 90%, indicating that the labeling is successful. Measurement method of labeling rate: The labeling rate of the reaction solution was determined by paper chromatography, Whatman filter paper was used as the carrier, and O.1mol / L HCl was used as the mobile phase for development. The labeling rate was measured by paper chromatography, and the free 131 I is distributed at the solvent front, while 131 I labeled s...

Embodiment 1-4131I

[0026] Example 1-4 131 Preparation of I-labeled sennoglycogen A

[0027] Weigh 2.0mg of powdered sennoglycogen A, dissolve in 1.0ml DMSO, shake and shake well to obtain 2.0mg / ml sennoglycogen A DMSO solution. Add 400 μl of sennoglycoside A DMSO solution with a concentration of 2.0 mg / ml to the prepared coated tube with a lodogen content of 40 μg, and add 100 μl of 200 μCI Na 131 I solution, oscillate and shake well, heat in a water bath at 45°C, react for about 90 minutes, take out the reaction solution to terminate the reaction, measure the labeling rate, and the labeling rate is greater than 90%, indicating that the labeling is successful.

[0028] Measurement method of labeling rate: The labeling rate of the reaction solution was determined by paper chromatography, Whatman filter paper was used as the carrier, and 0.1mol / L HCl was used as the mobile phase for development. The labeling rate was measured by paper chromatography, and the free 131 I is distributed at the sol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the field of medicines, in particular to the field of antitumor medicines, more specifically to an antitumor medicine. The purpose of the present invention is to provide a brand-new antitumor drug, and creatively discovers the application of isotope-labeled dianthrone compounds in the preparation of antitumor drugs. The compound disclosed in the present invention is used as a tumor targeting carrier, and can be selectively aggregated at the lesion after being labeled with a radioactive isotope. And the selectivity is high, the targeting is good, the side effect is small, and the tumor treatment effect is remarkable.

Description

technical field [0001] The present invention relates to the field of medicines, in particular to the field of antitumor medicines, and more specifically to the application of isotope-labeled dianthrone compounds in the preparation of antitumor medicines. Background technique [0002] Tumors are seriously threatening human health, and finding effective anti-tumor drugs and methods is an important research topic in the world medical community. In recent years, although humans have made some progress in tumor treatment such as surgery, chemotherapy, and radiotherapy. However, due to the low selectivity of the existing chemotherapeutic drugs and radiotherapy methods, while killing tumor cells, it also damages normal cells in the body, causing patients to often have obvious toxic and side effects during treatment, so looking for a tumor cell selection Antitumor drugs with high toxicity and strong killing effect, but with little side effects on normal tissues are very meaningful....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K51/04A61P35/00
Inventor 张健孙自平高萌蒋翠花李玥江骁姚楠黄德健
Owner JIANGSU PROVINCE INST OF TRADITIONAL CHINESE MEDICINE